🔎 Trials Near Me

Akèy › Maladi Crohn › Connecticut › New Haven

Etid klinik pou Maladi Crohn nan New Haven, CT

8 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote New Haven (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Ap rekriteFaz 3
  • Yale University School of Medicine-Digestive Disease ( Site 5019), New Haven
Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Ap rekriteFaz 2
  • Yale University School of Medicine /ID# 266786, New Haven
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • Medical Research Center of Connecticut, Hamden · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07499232

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven
  • Yale University, New Haven
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • Yale University Digestive Disease-Site Number: 8400108, New Haven
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Ap rekriteFaz 4
  • Medical Research Center of Connecticut, LLC, Hamden · 6 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Ap rekrite
  • Yale University, New Haven
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ap rekriteEtid obsèvasyon
  • Yale University School of Medicine, New Haven
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07237516

Etid Maladi Crohn nan lòt vil

Lòt etid nan New Haven

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.